## TDG: Transdigm Group Incorporated - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -2.0% below STRENGTH zone (3.0-6.0%); PEG 3.75 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1260.51)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. TransDigm group director Small sells $121.4 million in stock**
- Source: Investing.com | 20251210T030550 | Neutral | Relevance: 99%
-  Robert J. Small, a director at TransDigm Group INC, sold 90,953 shares of common stock totaling $121.4 million on December 9, 2025. The shares were held through Stockbridge Fund, L.P., and Stockbridge Partners LLC. This insider sale follows TransDigm's strong Q4 2025 financial results, which surpassed analyst expectations, leading to updated price targets from UBS and Stifel.

**2. Nebula Research & Development LLC Increases Stock Holdings in Transdigm Group Incorporated $TDG**
- Source: MarketBeat | 20251211T130856 | Bullish | Relevance: 98%
-  Nebula Research & Development LLC has significantly increased its stake in Transdigm Group Incorporated (NYSE:TDG) by 418.1% in Q2, bringing their total holdings to 2,575 shares valued at approximately $3.916 million. Despite substantial insider selling activity, institutional investors collectively own 95.78% of the company's stock. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $1,576.29, following strong Q3 earnings that surpassed expectations.

**3. First Trust Advisors LP Sells 5,324 Shares of Transdigm Group Incorporated $TDG**
- Source: MarketBeat | 20251211T000918 | Neutral | Relevance: 98%
- First Trust Advisors LP reduced its stake in Transdigm Group Incorporated (NYSE:TDG) by 18.1%, selling 5,324 shares and now owning 24,088 shares valued at $36.63 million. This comes amidst significant insider selling, with COO Joel Reiss and Director Kevin M. Stein selling a combined total of over 21,000 shares for approximately $29 million in recent transactions. Despite insider sales, institutional investors own 95.78% of TDG, and analysts maintain a "Moderate Buy" consensus rating with an average target price of $1,576.29.

**4. Transdigm Group (NYSE:TDG) Raised to Hold at Zacks Research**
- Source: MarketBeat | 20251210T120826 | Somewhat-Bullish | Relevance: 98%
-  Zacks Research has upgraded Transdigm Group (NYSE:TDG) from a "strong sell" to a "hold" rating and provided a FY2028 EPS estimate of $44.52. Despite recent insider selling, the stock maintains a consensus "Moderate Buy" rating with an average price target of $1,576.29, following a strong earnings beat and positive revenue growth. Several other analysts have also issued reports, with some increasing price targets and others slightly reducing them.

**5. 2,000 Shares in Transdigm Group Incorporated $TDG Purchased by WINTON GROUP Ltd**
- Source: MarketBeat | 20251209T141239 | Somewhat-Bullish | Relevance: 98%
-  WINTON GROUP Ltd significantly increased its stake in Transdigm Group Inc. (NYSE:TDG) by acquiring 2,000 shares valued at approximately $3.04 million during Q2. This comes as Transdigm surpassed Q3 earnings and revenue estimates and provided optimistic FY2026 guidance, reinforcing confidence among institutional investors who now own 95.78% of the company. Despite insider sales totaling over $78 million in the last 90 days, analysts maintain a "Moderate Buy" rating with a consensus price target of $1,576.29, suggesting continued positive outlook for the aerospace component supplier.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | Morgan Stanley | $1660 | $1600 | +4% |
| 2025-11-14 | JP Morgan | $1435 | $1405 | +2% |
| 2025-11-13 | RBC Capital | $1400 | $1385 | +1% |
| 2025-11-13 | BMO Capital | $1500 | $1420 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | Morgan Stanley | main | Overweight |
| 2025-11-14 | JP Morgan | main | Neutral |
| 2025-11-13 | RBC Capital | main | Sector Perform |
| 2025-11-13 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 26 ($1.90M) |
| Sells | 15 ($9.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+1.8%)
- Capital Internationa: 11.5% (+4.1%)
- Blackrock Inc.: 7.4% (-1.6%)
- Capital World Invest: 7.0% (-0.8%)
- JPMORGAN CHASE & CO: 4.5% (+26.5%)

### Key Risks

1. Insider selling cluster: $9.1M in recent transactions.
2. Valuation risk: PEG 3.7x with declining EPS estimates leaves no margin for error.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 5 raises (avg +3%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.75 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROA 11%, margin 24%). Balance sheet: strong liquidity (3.2x), $1.8B free cash flow. Insider selling cluster ($9.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $74.2B |
| Beta | 0.92 |
| 52W Range | $1183.60 - $1623.83 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.75 |
| Forward P/E | 28.8 |
| Current P/E | 34.3 |
| YoY Growth | 19.1% |
| EPS Direction | FALLING |

### Technicals

MRS_10 stable at -2.0% (minimal 5-day change). Below STRENGTH zone by 5.0pp (needs >3.0% for momentum thesis). Underperforming sector by 3.2pp, stock-specific weakness. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram bearish (-5.22), momentum weakening. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.01% (CS: 16) | Weak |
| RSI_14 | 46.4 | Neutral |
| MACD Histogram | -5.22 | Bearish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 1.002x | Above |
| vs SMA200 | 0.952x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1317.49
- **Stop Loss:** $1260.51 (4.3% risk)
- **Target:** $1374.47 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 24
- **Position Value:** $31,619.76
- **Portfolio %:** 31.62%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-03 (Est: $8.00)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.05 | $10.82 | +7.6% |
| 2025Q2 | $9.90 | $9.60 | -3.0% |
| 2025Q1 | $8.95 | $9.11 | +1.8% |
| 2024Q4 | $7.74 | $7.83 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*